Ebola post from elsewhere and a poster who may not be posting here:
The Ebola update is great news. This is the first reference after the 14/10/14 press release and the 29/10/14 update mentioning the ability of their N-Assay to detect viruses and is welcome news. I would expect Nanologix to either release as little or as much news as possible about this development depending on who is performing the work and what restrictions exist on sharing of news.
Excerpt from the 14/10/14 press release:
"The Company has been aware of the virus detection capabilities of the technology since the N-Assay development. Viruses viewed as public health concerns prior to Ebola and Enterovirus were Influenza, the common cold, and HIV, none of which have an immediate or near-immediate threat of mortality. Until recently, NanoLogix has been focused solely on the use of their N-Assay kit for bacteria detection and identification. Now, with the recent outbreaks of both Ebola and Enterovirus there is an immediate need for configuration of the N-Assay for viruses. NanoLogix facilities are not designed for work on viruses, for this specific project we are seeking a corporate partner with the facilities necessary to bring the new N-Assay (V) to the market as quickly as possible. We consider this a matter of national security and an emergency priority. We are in discussions with potential partners, positioned with strong ties to the US government, who understand the serious threat these viruses represent.”
This is the an excerpt from the update I received through the Nanologix newsletter on 29/10/14:
"As a result, NanoLogix N-Assay (V) is currently being evaluated by pharmaceutical companies for use as a simple rapid diagnostic tool for viruses for use in remote locations in close proximity to outbreak events. Nanologix this week signed two Mutual Confidentiality Agreements with US corporations interested in their technology. "
To me this demonstrates a methodical approach to testing with their new technology application for something that had not been tested for in the past. Nanologix clearly stated that they do not have facilities for virus testing, that they were/are looking for partners for that particular purpose, and that they signed confidentiality agreements with two companies likely for research into Ebola virus detection.
Now, in January, they release information on a <3 hour result related to Ebola using that same N-Assay mentioned in the news from October. Since they have already mentioned that they do not have facilities for testing for viruses, could it be any clearer that someone is working on that virus detection with their technology?
The fact that Ebola is infecting and killing people in West Africa and not in Manhattan, New York, at the UN, may make it seem as though Ebola is not important, but it is killing people and it is not "yesterday's news" for those who are at risk. It is a permanent threat until a viable vaccine is developed and administered throughout the affected areas.
The Ebola update is great news. This is the first reference after the 14/10/14 press release and the 29/10/14 update mentioning the ability of their N-Assay to detect viruses and is welcome news. I would expect Nanologix to either release as little or as much news as possible about this development depending on who is performing the work and what restrictions exist on sharing of news.
Excerpt from the 14/10/14 press release:
"The Company has been aware of the virus detection capabilities of the technology since the N-Assay development. Viruses viewed as public health concerns prior to Ebola and Enterovirus were Influenza, the common cold, and HIV, none of which have an immediate or near-immediate threat of mortality. Until recently, NanoLogix has been focused solely on the use of their N-Assay kit for bacteria detection and identification. Now, with the recent outbreaks of both Ebola and Enterovirus there is an immediate need for configuration of the N-Assay for viruses. NanoLogix facilities are not designed for work on viruses, for this specific project we are seeking a corporate partner with the facilities necessary to bring the new N-Assay (V) to the market as quickly as possible. We consider this a matter of national security and an emergency priority. We are in discussions with potential partners, positioned with strong ties to the US government, who understand the serious threat these viruses represent.”
This is the an excerpt from the update I received through the Nanologix newsletter on 29/10/14:
"As a result, NanoLogix N-Assay (V) is currently being evaluated by pharmaceutical companies for use as a simple rapid diagnostic tool for viruses for use in remote locations in close proximity to outbreak events. Nanologix this week signed two Mutual Confidentiality Agreements with US corporations interested in their technology. "
To me this demonstrates a methodical approach to testing with their new technology application for something that had not been tested for in the past. Nanologix clearly stated that they do not have facilities for virus testing, that they were/are looking for partners for that particular purpose, and that they signed confidentiality agreements with two companies likely for research into Ebola virus detection.
Now, in January, they release information on a <3 hour result related to Ebola using that same N-Assay mentioned in the news from October. Since they have already mentioned that they do not have facilities for testing for viruses, could it be any clearer that someone is working on that virus detection with their technology?
The fact that Ebola is infecting and killing people in West Africa and not in Manhattan, New York, at the UN, may make it seem as though Ebola is not important, but it is killing people and it is not "yesterday's news" for those who are at risk. It is a permanent threat until a viable vaccine is developed and administered throughout the affected areas.
